Skip to main content
Market Insights Health
- United States
- The projected revenue for the Pharmaceuticals market in the United States is expected to reach US$630.30bn in 2024.
- Among the various markets, Oncology Drugs is anticipated to be the largest, with a projected market volume of US$103.90bn in the same year.
- Looking ahead, the market is expected to experience a steady annual growth rate of 4.65% from 2024 to 2029, resulting in a market volume of US$791.30bn by 2029.
- It is worth noting that in global comparison, United States is expected to generate the highest revenue in the Pharmaceuticals market, with US$630.30bn in 2024.
- The pharmaceutical market in the United States is experiencing a surge in demand for personalized medicine and targeted therapies.
Key regions: United States, China, Germany, Japan, Europe
Definition:
The Pharmaceuticals market covers remedies used to cure, treat, prevent, and diagnose diseases. These small molecule drugs or biologic medical products may be called drugs, medications, or medicines. Prescription drugs and over-the-counter (OTC) drugs are both included. Depending on the regulations in each country, these products are provided by pharmacies, hospitals, physicians, and/or drug stores, and/or they can be bought elsewhere. They may be administered in the form of pills, capsules, gels, ointments, injections, infusions, lozenges, or aerosols/sprays.
Structure:
The market is subdivided into Oncology Drugs, Anti-Diabetes Drugs, Anti-Rheumatic Drugs, Vaccines, Dermatological Drugs, Antiviral Drugs, Immunosuppressants, Bronchodilator Drugs, Sensory Organ Drugs, Anti-Hypertensive Drugs, Anti-Coagulants, Anti-Fibrinolytic Drugs, Multiple Sclerosis Drugs, Lipid-Lowering Agents and Other Pharmaceuticals. The Pharmaceuticals market is organized in markets that cover drugs used in specific medical fields, i.e., medicines for a specific disesase or a certain type of medicine. They include original brands, biosimilars, generics, and orphan drugs.The Oncology Drugs market covers pharmaceutical products specifically developed for the treatment and management of various cancers. The Anti-Diabetes Drugs market covers medications designed to manage blood glucose levels and improve insulin sensitivity in individuals with diabetes. The market Anti-Rheumatic Drugs includes pharmaceuticals specifically developed to alleviate symptoms, reduce inflammation, and modify the progression of rheumatic diseases. The Dermatological Drugs market covers pharmaceuticals formulated to treat and manage a wide range of skin conditions such as eczema, acne, and rosacea. The Antiviral Drugs market includes medications designed to treat viral infections and reducing the severity and duration of symptoms. The Immunosuppressants market covers pharmaceuticals that suppress the immune system's activity. The Bronchodilator Drugs market covers pharmaceuticals designed to relax and widen the airways in the lungs. The Sensory Organ Drugs market covers pharmaceuticals targeting the treatment of disorders and conditions affecting sensory organs such as the eyes, ears and nose. The Anti-hypertensive Drugs market covers pharmaceuticals designed to lower blood pressure levels. The Anti-Coagulants Drugs market covers pharmaceuticals developed to prevent the formation of blood clots or to dissolve existing clots. The Anti-Fibrinolytics Drugs market covers pharmaceuticals designed to inhibit the breakdown of blood clots. The Multiple Sclerosis Drugs market covers pharmaceuticals aimed at managing and modifying the course of multiple sclerosis. The Lipid-Lowering Agents market covers pharmaceuticals developed to reduce levels of cholesterol and other lipids in the blood. The Other Pharmaceuticals market provides information on additional specialties that are not covered by the main markets.
Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).
Company examples: Novartis, Roche, Pfizer, Merck & Co, Johnson & Johnson, AbbVie, Sanofi.
in-scope
- Prescription and over-the-counter (OTC) drugs
- Small molecule drugs and biologic medical products
- Vaccines
- Original brands, biosimilars, and generics
out-of-scope
- Veterinary drugs
- Medical devices
- Profit of wholesalers, pharmacies, hospitals, and clinics
Pharmaceuticals
- Oncology Drugs
- Anti-Diabetes Drugs
- Anti-Rheumatic Drugs
- Vaccines
- COVID-19 Vaccines
- Other Vaccines
- Dermatological Drugs
- Antiviral Drugs
- Immunosuppressants
- Bronchodilator Drugs
- Sensory Organ Drugs
- Anti-Hypertensive Drugs
- Anti-Coagulants
- Anti-Fibrinolytic Drugs
- Multiple Sclerosis Drugs
- Lipid-Lowering Agents
- Other Pharmaceuticals
Related markets:
Medical Technology
OTC Pharmaceuticals
Digital Health
Hospitals
Cannabis
Mental Health
Pharmacies
Please wait
Download PDF FAQs and more info on the methodology
Market
Region
Region comparison
Currency
Analyst Opinion
The United States has a thriving pharmaceutical market that is constantly evolving to meet the changing needs of patients. Customer preferences: Trends in the market: Local special circ*mstances: Underlying macroeconomic factors:
Methodology
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.
Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.
Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.
Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Overview
- Revenue
- Analyst Opinion
- Key Players
- Global Comparison
- Methodology
- Key Market Indicators
Please wait
Contact
Get in touch with us. We are happy to help.
Meredith Alda
Sales Manager– Contact (United States)
Tel
+1 914 619-5895
Mon - Fri, 9am - 6pm (EST)
Yolanda Mega
Operations Manager– Contact (Asia)
Tel
+65 6995 6959
Mon - Fri, 9am - 5pm (SGT)
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)
Mon - Fri, 10:00am - 6:00pm (JST)
Lodovica Biagi
Director of Operations– Contact (Europe)
Tel
+44 (0)20 8189 7000
Mon - Fri, 9:30am - 5pm (GMT)
Carolina Dulin
Group Director - LATAM– Contact (Latin America)
Tel
+1 212 419-5774
Mon - Fri, 9am - 6pm (EST)
Unlock Market Insights with a Professional Account
- Get immediate access to all Market Insights, reports & statistics
- Download data in multiple formats for collaborative research
- Includes usage & publication rights for sharing data externally
Buy Professional Account
Already have an account? Login
